FDA Approved: ENOXAPARIN SODIUM — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for ENOXAPARIN SODIUM by Sandoz Inc, signaling an approved change to the product's status under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• Enoxaparin sodium (Enoxaparin sodium)

Snippet

SUPPL AP for ENOXAPARIN SODIUM (ENOXAPARIN SODIUM)